コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 it was eliminated 57.7 +/- 0.36% faster as a glucuronide conjugate.
2 metabolites and the corresponding sulfo and glucuronide conjugates.
3 echin after enzymatic release of sulfate and glucuronide conjugates.
4 over-the-counter drugs as their sulfate and glucuronide conjugates.
5 a significant factor in renal elimination of glucuronide conjugates.
7 ty is expected to reduce the reactivation of glucuronide-conjugated drugs in the intestine, thereby r
9 st demonstrated by the identification of two glucuronide-conjugated metabolite standards spiked in ur
11 ound to have great potential for identifying glucuronide-conjugated metabolites, as well as other kin
12 res were structurally annotated as potential glucuronide-conjugated metabolites, resulting in the ide
14 ent glucuronidation to form a novel O-linked glucuronide conjugate, O-(beta-D-glucosidurony1)-2-hydro
15 es and the urinary excretion level of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx--N2-(beta-
17 tographic (HPLC) analysis, and found to be a glucuronide conjugate of a known DCF metabolite, 4'-hydr
18 ughput method to directly analyze the intact glucuronide conjugate of HP (HP-G) in human urine after
20 y either bacteria-mediated hydrolysis of the glucuronide conjugate of the active metabolite 7-ethyl-1
21 e metabolites were identified as sulfate and glucuronide conjugates of a ring hydroxy-substituted met
27 se activity was stimulated by bile acids and glucuronide conjugates, reaching 170 +/- 28 nmol min-1 m
28 und decrease in the biliary clearance of the glucuronide conjugates was observed in Bcrp-deficient mo
32 roid conjugates in all sample types, whereas glucuronide conjugates were hydrolyzed in the presence o